Large language models and multimodal foundation models for precision oncology
Open accessAbstract
The technological progress in artificial intelligence (AI) has massively accelerated since 2022, with far-reaching implications for oncology and cancer research. Large language models (LLMs) now perform at human-level competency in text processing. Notably, both text and image processing networks are increasingly based on transformer neural networks. This convergence enables the development of multimodal AI models that take diverse types of data as an input simultaneously, marking a qualitative shift from specialized niche models which were prevalent in the 2010s. This editorial summarizes these developments, which are expected to impact precision oncology in the coming years.
Verified 2026-10-07 · 1 reference not checked yet
AI snapshot
Written from the paper’s full text.
TL;DR
This editorial summarizes how large language models (LLMs) and multimodal foundation models are expected to affect precision oncology, enabled by transformer architectures and expanding patient data. It highlights promising applications alongside challenges in data quality, clinical integration, regulation, evaluation, and interpretability.
Key findings
- LLMs now perform at human-level competency in text processing, and transformer neural networks increasingly underlie both text and image processing, enabling multimodal AI models that take diverse data types simultaneously.
- Medical adaptations include Bio-BERT for biomedical text mining, Med-PaLM, and Med-PaLM 2, which scored 86.5% on the US Medical Licensing Exam (USMLE).
- Foundation models can reduce data requirements for specialized tasks; for example, linking chest X-rays to report text can alleviate manual annotation while preserving human-level accuracies and outperforming supervised methods.
- The paper identifies challenges for oncology adoption: careful assessment of training data quality, quantity, and diversity; expert-guided system design; legal and regulatory approval as medical devices; ongoing evaluation; and limited interpretability, especially for text or multimodal tasks.
Methods
- This is an editorial/narrative overview, not a primary research study.
- It synthesizes cited literature and examples across oncology, medical imaging, pathology, EHRs, and foundation models.
- No systematic search, dataset, or statistical analysis is described.
Limitations
- The paper states that more scientific evidence is required to ensure LLMs and multimodal models provide quantifiable benefits in oncology.
- It states that data quality, quantity, and diversity must be carefully assessed; integration should involve medical professionals, patient advocates, and the broader scientific community; regulatory approval is required; ongoing evaluation is needed; and interpretability remains a concern, with fewer explainability studies for text or multimodal medical tasks.
- Evident from the text: as an editorial, it provides no original empirical validation or quantitative synthesis, and several cited examples are preprints.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 28 cited sources checked · 0 supported · 0 flagged
- Premisecitation
Multimodal AI systems have been evaluated for various applications in precision oncology, such as outcome predictions.
“Multimodal AI systems have been evaluated for various applications in precision oncology, such as outcome predictions14,15.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [14] Chen, R. J. et al. Pan-cancer integrative histology-genomic analysis via multimodal deep learning. Cancer Cell 40, 865–878.e6 (2022). source
Not checked in the free run.
- cites [15] Lipkova, J. et al. Artificial intelligence for multimodal data integration in oncology. Cancer Cell 40, 1095–1110 (2022). source
Not checked in the free run.
- Premisecitation
Foundation models reduce the data requirements for specialized tasks, for example in predicting diseases from retinal photographs.
“Foundation models reduce the data requirements for specialized tasks, for example in predicting diseases from retinal photographs17.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] Zhou, Y. et al. A foundation model for generalizable disease detection from retinal images. Nature https://doi.org/10.1038/s41586-023-06555-x (2023). source
Not checked in the free run.
- Premisecitation
Fine-tuned LLMs have been shown to solve real-world problems such as predicting clinical outcomes just based on unstructured text data in EHRs.
“However, fine-tuned LLMs have been shown to solve real-world problems such as predicting clinical outcomes just based on unstructured text data in EHRs13.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Jiang, L. Y. et al. Health system-scale language models are all-purpose prediction engines. Nature 619, 357–362 (2023). source
Not checked in the free run.
- Premisecitation
Between 2012 and 2022, neural networks were applied in numerous studies primarily focused on oncological imaging or text.
“Between 2012 and 2022, neural networks were applied in numerous studies that primarily focused on the analysis of oncological imaging or text1.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Shmatko, A., Ghaffari Laleh, N., Gerstung, M. & Kather, J. N. Artificial intelligence in histopathology: enhancing cancer research and clinical oncology. Nat. Cancer 3, 1026–1038 (2022). source
Not checked in the free run.
- Premisecitation
The integration of foundation models in operable clinical software systems faces legal and regulatory challenges because these models require approval as medical devices.
“Thirdly, the integration of such models in operable clinical software systems faces legal and regulatory challenges because these models require approval as medical devices26.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Gilbert, S., Harvey, H., Melvin, T., Vollebregt, E. & Wicks, P. Large language model AI chatbots require approval as medical devices. Nat. Med. https://doi.org/10.1038/s41591-023-02412-6 (2023). source
Not checked in the free run.
- Premisecitation
Recent advances with open-sourced models yield the perspective of de novo model training and development at much lower financial and computational burdens.
“Recent advances with open-sourced models yield the perspective of de novo model training and development at much lower financial and computational burdens24.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Li, C. et al. LLaVA-Med: training a large language-and-vision assistant for biomedicine in one day. Preprint at https://arxiv.org/abs/2306.00890 (2023).
Not checked in the free run.
- Classified as probably not a substantial claim. 22
- May combine two claims. 9
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationModel performance scales with size (number of parameters), and larger models show emergent behavior: they acquire an understanding of concepts underlying training data without explicit training.
“Notably, model performance scales with size, i.e. number of parameters, and larger models show emergent behavior9: They acquire an understanding of concepts underlying the training data without having been explicitly trained on this.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Wei, J. et al. Emergent abilities of large language models. Preprint at https://arxiv.org/abs/2206.07682 (2022).
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe technological shift to convolutional neural networks was subsequently integrated into medical research.
“This technological shift was subsequently integrated into medical research1”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Shmatko, A., Ghaffari Laleh, N., Gerstung, M. & Kather, J. N. Artificial intelligence in histopathology: enhancing cancer research and clinical oncology. Nat. Cancer 3, 1026–1038 (2022). source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningThe transformer neural network architecture enables multimodality.
“This network architecture is well suited for almost any type of data, and enables multimodality.”
Quote in the paperNot a substantial claim- Rests on an assumption: Today’s LLMs are transformer neural networks.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThe transformer neural network architecture is well suited for almost any type of data.
“This network architecture is well suited for almost any type of data, and enables multimodality.”
Quote in the paperNot a substantial claim- Rests on an assumption: Today’s LLMs are transformer neural networks.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHigh-profile initiatives such as IBM Watson did not achieve their projected outcomes.
“However, high-profile and ambitious initiatives, such as IBM Watson, did not achieve their projected outcomes4.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Schmidt, C. M. D. Anderson breaks with IBM Watson, raising questions about artificial intelligence in oncology. J. Natl Cancer Inst. 109 (2017). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA common application area under exploration for LLMs is healthcare.
“A common application area under exploration for these LLMs is healthcare7.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Bubeck, S. et al. Sparks of artificial general intelligence: early experiments with GPT-4. Preprint at https://arxiv.org/abs/2303.12712 (2023).
Not checked in the free run.
May combine two claims.
PremisecitationFoundation models can alleviate the need for time-consuming manual annotation while preserving human-level accuracies and outperforming supervised methods.
“For instance, linking images from chest X-rays to corresponding report text data, and foundation models can alleviate the need for time-consuming and laborious manual annotation while preserving human-level accuracies and outperforming supervised methods18.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Tiu, E. et al. Expert-level detection of pathologies from unannotated chest X-ray images via self-supervised learning. Nat. Biomed. Eng. 6, 1399–1406 (2022). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMed-PaLM 2 scored 86.5% in the US Medical Licensing Exam (USMLE).
“Recently, Google has introduced the next iteration, Med-PaLM 2, which scored a high 86.5% in the US Medical Licensing Exam (USMLE)12.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Singhal, K. et al. Towards expert-level medical question answering with large language models. Preprint at https://arxiv.org/pdf/2305.09617.pdf (2023).
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBio-BERT showed robust capabilities for biomedical text mining.
“One of the first language models to be successfully transferred to the medical domain was Bio-BERT, which showed robust capabilities for biomedical text mining10.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Lee, J. et al. BioBERT: a pre-trained biomedical language representation model for biomedical text mining. Bioinformatics 36, 1234–1240 (2020). source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningMore scientific evidence is required to ensure that LLMs and multimodal models provide quantifiable benefits in oncology.
“However, more scientific evidence is required to ensure that LLMs and multimodal models provide quantifiable benefits in oncology.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe landscape of AI in oncology changed in 2022 and 2023 with the advent of large language models and multimodal AI models.
“This landscape changed in 2022 and 2023 with the advent of two key innovations: large language models (LLMs) and multimodal AI models.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationGPT-4 displayed much-improved knowledge retrieval and logical reasoning capacities with far fewer hallucinations compared to GPT-3.5.
“It was later succeeded by GPT-4, which displayed much-improved knowledge retrieval and logical reasoning capacities with far fewer hallucinations7.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Bubeck, S. et al. Sparks of artificial general intelligence: early experiments with GPT-4. Preprint at https://arxiv.org/abs/2303.12712 (2023).
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe training data for LLMs is a large and diverse amount of text, usually sourced from the internet and commercial data providers, and can include diverse types of medical data.
“The training data for these models is a large and diverse amount of text, usually sourced from the internet and commercial data providers, and can include diverse types of medical data7.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Bubeck, S. et al. Sparks of artificial general intelligence: early experiments with GPT-4. Preprint at https://arxiv.org/abs/2303.12712 (2023).
Not checked in the free run.
May combine two claims.
InterpretationcitationThe decade 2012-2022 can be viewed as a stabilization phase for AI applications in oncology, marked by incremental improvements and specialized uses, predominantly in image analysis.
“This decade can be viewed as a stabilization phase for AI applications in oncology, marked by incremental improvements and specialized uses, predominantly in image analysis5.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] He, J. et al. The practical implementation of artificial intelligence technologies in medicine. Nat. Med. 25, 30–36 (2019). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA 2017 publication demonstrated neural network performance on par with human experts across large image datasets.
“most notably evidenced by a 2017 publication demonstrating neural network performance on par with human experts across large image datasets2”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Esteva, A. et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature 542, 115–118 (2017). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe most successful LLMs have recently relied on transformer-based architectures pertaining to their attention mechanisms.
“While potentially this purpose can also be fulfilled by various model architectures, the most successful models have recently relied on transformer-based architectures pertaining to their attention mechanisms8.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Vaswani, A. et al. Attention is all you need. Preprint at https://arxiv.org/abs/1706.03762 (2017).
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMed-PaLM outperformed its previous version in medical use cases.
“Also, Google’s LLM “PALM” was fine-tuned on medical training data, resulting in Med-PaLM, which outperformed its previous version in medical use cases11.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Singhal, K. et al. Large language models encode clinical knowledge. Nature 620, 172–180 (2023). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHardware improvements have gradually lowered computational barriers for training and deploying resource-intensive models, broadening the user base capable of developing and refining AI algorithms.
“In parallel, hardware improvements have gradually lowered the computational barriers for training and deploying resource-intensive models, thus broadening the user base capable of developing and refining AI algorithms3.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Topol, E. J. High-performance medicine: the convergence of human and artificial intelligence. Nat. Med. 25, 44–56 (2019). source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
InterpretationreasoningThe convergence of text and image processing networks on transformer architectures enables the development of multimodal AI models that take diverse data types as input simultaneously, marking a qualitative shift from specialized niche models prevalent in the 2010s.
“This convergence enables the development of multimodal AI models that take diverse types of data as an input simultaneously, marking a qualitative shift from specialized niche models which were prevalent in the 2010s.”
Quote in the paperNot a substantial claim- Rests on an assumption: LLMs now perform at human-level competency in text processing.
- Rests on an assumption: Both text and image processing networks are increasingly based on transformer neural networks.
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningOverall, the advancements in LLMs and multimodal models have the potential to impact the practice of oncology through many different applications.
“Overall, the advancements in LLMs and multimodal models have the potential to impact the practice of oncology through many different applications (Fig. 1C).”
Quote in the paperNot a substantial claim- Rests on an assumption: The technological progress in AI has massively accelerated since 2022.
- Rests on an assumption: LLMs now perform at human-level competency in text processing.
- Rests on an assumption: Both text and image processing networks are increasingly based on transformer neural networks.
- Rests on an assumption: The volume of patient-specific data in oncology is rapidly expanding due to the widespread introduction of electronic health records, advances in medical imaging, and the integration of large-scale genomic analyses into clinical routine.
- Rests on an assumption: AI and machine learning have shown promise in helping healthcare professionals to process large oncology data.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based).
Interpretationnone givenAs foundation models diversify their capabilities, they open up new avenues for their potential application in oncology and cancer research, such as multimodal diagnostics and drug discovery.
“As foundation models diversify their capabilities, they open up new avenues for their potential application in oncology and cancer research, such as multimodal diagnostics and drug discovery.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA prominent concern of AI models based on neural network architecture is their often criticized lack of interpretability, earning them the term 'black boxes'.
“Lastly, a prominent concern of AI models based on neural network architecture is their often criticized lack of interpretability which earned them the term ‘black boxes’27,28.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationWhile substantial progress has been made in model explainability for image-related tasks, fewer studies address explainability in text processing or multimodal tasks in medicine.
“While substantial progress has been made in model explainability for image-related tasks, fewer studies address explainability in text processing or multimodal tasks in medicine29.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Tjoa, E. & Guan, C. A survey on explainable artificial intelligence (XAI): toward medical XAI. IEEE Trans. Neural Netw. Learn Syst. 32, 4793–4813 (2021). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEarly generalist models show consistently high performance across a variety of medical domains and tasks integrating knowledge from diverse domains.
“Furthermore, early generalist models have been introduced which show consistently high performance across a variety of medical domains and tasks integrating knowledge from diverse domains22,23.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [22] Zhang, K. et al. BiomedGPT: a unified and generalist biomedical generative pre-trained transformer for vision, language, and multimodal tasks. Preprint at https://arxiv.org/abs/2305.17100 (2023).
Not checked in the free run.
- cites [23] Tu, T. et al. Towards generalist biomedical AI. Preprint at https://ai.nejm.org/doi/full/10.1056/AIoa2300138 (2023).
Not checked in the free run.
May combine two claims.
PremisecitationIn pathology, large image datasets linked with contextual knowledge and case-specific information yield high performance in disease detection and biomarker prediction and can inform further diagnostic procedures such as additional stains.
“Similar examples exist in pathology, where large image datasets are linked with contextual knowledge and case-specific information yielding high performance in disease detection as well as biomarker prediction and can also inform further diagnostic procedures such as additional stains20,21.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [20] Vorontsov, E. et al. Virchow: a million-slide digital pathology foundation model. Preprint at https://arxiv.org/abs/2309.07778 (2023).
Not checked in the free run.
- cites [21] Lu, M. Y. et al. A foundational multimodal vision language AI assistant for human pathology. Preprint at https://arxiv.org/abs/2312.07814 (2023).
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThere is a trend towards improving model efficiency by reducing model size while retaining model performance, given the resource-intensive nature of billion-parameter models.
“Given the resource-intensive nature of training models with parameter sizes in the billions, there is a trend towards improving model efficiency by reducing model size while retaining model performance.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The technological progress in AI has massively accelerated since 2022.
“The technological progress in artificial intelligence (AI) has massively accelerated since 2022, with far-reaching implications for oncology and cancer research.”
The paper relies on this without support.
LLMs now perform at human-level competency in text processing.
“Large language models (LLMs) now perform at human-level competency in text processing.”
The paper relies on this without support.
Both text and image processing networks are increasingly based on transformer neural networks.
“Notably, both text and image processing networks are increasingly based on transformer neural networks.”
The paper relies on this without support.
The volume of patient-specific data in oncology is rapidly expanding due to the widespread introduction of electronic health records, advances in medical imaging, and the integration of large-scale genomic analyses into clinical routine.
“The volume of patient-specific data in oncology is rapidly expanding. This is due to the widespread introduction of electronic health records (EHRs), advances in medical imaging, and the integration of large-scale genomic analyses into clinical routine.”
The paper relies on this without support.
AI and machine learning have shown promise in helping healthcare professionals to process large oncology data.
“Artificial intelligence (AI) and machine learning (ML) have shown promise in helping healthcare professionals to process such data.”
The paper relies on this without support.
Today’s LLMs are transformer neural networks.
“Today’s LLMs are transformer neural networks.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The predominance of pan-cancer clinical domains suggests that researchers leverage the versatility of LLMs to address broad oncological challenges across multiple cancer types, likely due to the generalizable nature of these models for various cancer data.
“This suggests that researchers leverage the versatility of LLMs to address broad oncological challenges across multiple cancer types, likely due to the generalizable nature of these models for various cancer data [42].”
From Large Language Model Applications for Health Information Extraction in Oncology: Scoping Review (2025) · cites this paper as [42]
Cites
Dermatologist-level classification of skin cancer with deep neural networks
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362 · see citing works
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450 · cited 1× · see citing works
“In parallel, hardware improvements have gradually lowered the computational barriers for training and deploying resource-intensive models, thus broadening the user base capable of developing and re fi ning AI algorithms 3 .”
BackgroundBioBERT: a pre-trained biomedical language representation model for biomedical text mining
Lee, J., Yoon, W., Kim, S., Kim, D., Kim, S., So, C. H., & Kang, J. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btz682 · Cited by 7,218 · cited 1× · see citing works
“One of the fi rst language models to be successfully transferred to the medical domain was Bio-BERT, which showed robust capabilities for biomedical text mining 10 .”
BackgroundLarge language models encode clinical knowledge
Singhal, K., Azizi, S., Tu, T., Mahdavi, S. S., Wei, J., Chung, H. W., Scales, N., Tanwani, A., Cole-Lewis, H., Pfohl, S., et al. (2023) · Nature · doi:10.1038/s41586-023-06291-2 · Cited by 4,083 · cited 1× · see citing works
“Also, Google ’ s LLM “ PALM ” was fi ne-tuned on medical training data, resulting in Med-PaLM, which outperformed its previous version in medical use cases 11 .”
MethodA Survey on Explainable Artificial Intelligence (XAI): Toward Medical XAI
Tjoa, E., & Guan, C. (2021) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2020.3027314 · Cited by 2,524 · see citing works
The practical implementation of artificial intelligence technologies in medicine
He, J., Baxter, S. L., Xu, J., Xu, J., Zhou, X., & Zhang, K. (2019) · Nature Medicine · doi:10.1038/s41591-018-0307-0 · Cited by 2,246 · cited 1× · see citing works
“This decadecan be viewed as a stabilization phase for AI applications in oncology, marked by incremental improvements and specialized uses, predominantly in image analysis 5 .”
BackgroundFoundation models for generalist medical artificial intelligence
Moor, M., Banerjee, O., Abad, Z. S. H., Krumholz, H. M., Leskovec, J., Topol, E. J., & Rajpurkar, P. (2023) · Nature · doi:10.1038/s41586-023-05881-4 · Cited by 2,028 · cited 1× · see citing works
“Whenever a model is pre-trained on large and diverse tasks, and is subsequently applied to specialized tasks, it can be referred to as a “ foundation model ” 16 .”
BackgroundCan we open the black box of AI?
Castelvecchi, D. (2016) · Nature · doi:10.1038/538020a · Cited by 1,773 · cited 1× · see citing works
“Lastly, a prominent concern of AI models based on neural network architecture is their often criticized lack of interpretability which earned them the term ‘ black boxes ’ 27,28 .”
BackgroundToward expert-level medical question answering with large language models
Singhal, K., Tu, T., Gottweis, J., Sayres, R., Wulczyn, E., Amin, M., Hou, L., Clark, K., Pfohl, S. R., Cole-Lewis, H., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03423-7 · Cited by 1,734 · see citing works
Sparks of Artificial General Intelligence: Early experiments with GPT-4
Bubeck, S., Chandrasekaran, V., Eldan, R., Gehrke, J., Horvitz, E., Kamar, E., Lee, P., Lee, Y. T., Li, Y., Lundberg, S., et al. (2023) · arXiv · doi:10.48550/arxiv.2303.12712 · Cited by 1,526 · see citing works
The future landscape of large language models in medicine
Clusmann, J., Kolbinger, F. R., Muti, H. S., Carrero, Z. I., Eckardt, J.-N., Laleh, N. G., Löffler, C. M. L., Schwarzkopf, S.-C., Unger, M., Veldhuizen, G. P., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00370-1 · Cited by 1,045 · cited 1× · see citing works
“LLMs are deep learning models that serve the purpose of both processing and generating primarily text-based data 6 .”
BackgroundSelf-citationA foundation model for generalizable disease detection from retinal images
Zhou, Y., Chia, M. A., Wagner, S. K., Ayhan, M. S., Williamson, D. J., Struyven, R. R., Liu, T., Xu, M., Lozano, M. G., Woodward-Court, P., et al. (2023) · Nature · doi:10.1038/s41586-023-06555-x · Cited by 1,014 · cited 1× · see citing works
“Foundation models reduce the data requirements for specialized tasks, for example in predicting diseases from retinal photographs 17 .”
Artificial intelligence for multimodal data integration in oncology
Lipkova, J., Chen, R. J., Chen, B., Lu, M. Y., Barbieri, M., Shao, D., Vaidya, A. J., Chen, C., Zhuang, L., Williamson, D. F. K., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.09.012 · Cited by 777 · see citing works
Pan-cancer integrative histology-genomic analysis via multimodal deep learning
Chen, R. J., Lu, M. Y., Williamson, D. F. K., Chen, T. Y., Lipkova, J., Noor, Z., Shaban, M., Shady, M., Williams, M., Joo, B., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.07.004 · Cited by 660 · cited 1× · see citing works
“Multimodal AI systems have been evaluated for various applications in precision oncology, such as outcome predictions 14,15 .”
MethodLLaVA-Med: Training a Large Language-and-Vision Assistant for Biomedicine in One Day
Li, C., Wong, C., Zhang, S., Usuyama, N., Liu, H., Yang, J., Naumann, T., Poon, H., & Gao, J. (2023) · arXiv · doi:10.48550/arxiv.2306.00890 · Cited by 590 · see citing works
A foundation model for clinical-grade computational pathology and rare cancers detection
Vorontsov, E., Bozkurt, A., Casson, A., Shaikovski, G., Zelechowski, M., Severson, K., Zimmermann, E., Hall, J., Tenenholtz, N., Fusi, N., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03141-0 · Cited by 572 · see citing works
de Hond, A. A. H., Leeuwenberg, A. M., Hooft, L., Kant, I. M. J., Nijman, S. W. J., van Os, H. J. A., Aardoom, J. J., Debray, T. P. A., Schuit, E., van Smeden, M., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-021-00549-7 · Cited by 499 · cited 1× · see citing works
“Firstly, the underlying data the model is trained on has to be carefully assessed for quality, quantity, and diversity 25 .”
BackgroundTowards Generalist Biomedical AI
Tu, T., Azizi, S., Driess, D., Schaekermann, M., Amin, M., Chang, P.-C., Carroll, A., Lau, C., Tanno, R., Ktena, I., et al. (2024) · NEJM AI · doi:10.1056/aioa2300138 · Cited by 483 · see citing works
Towards Generalist Biomedical AI
Tu, T., Azizi, S., Driess, D., Schaekermann, M., Amin, M., Chang, P.-C., Carroll, A., Lau, C., Tanno, R., Ktena, I., et al. (2023) · arXiv · doi:10.48550/arxiv.2307.14334 · Cited by 483 · see citing works
Health system-scale language models are all-purpose prediction engines
Jiang, L. Y., Liu, X. C., Nejatian, N. P., Nasir-Moin, M., Wang, D., Abidin, A., Eaton, K., Riina, H. A., Laufer, I., Punjabi, P., et al. (2023) · Nature · doi:10.1038/s41586-023-06160-y · Cited by 460 · cited 2× · see citing works
“Thisis due to the widespread introduction of electronic health records (EHRs), advances in medical imaging, and the integration of large-scale genomic analyses into clinical routine.”
BackgroundArtificial intelligence in histopathology: enhancing cancer research and clinical oncology
Shmatko, A., Ghaffari Laleh, N., Gerstung, M., & Kather, J. N. (2022) · Nature Cancer · doi:10.1038/s43018-022-00436-4 · Cited by 446 · see citing works
Self-citationTiu, E., Talius, E., Patel, P., Langlotz, C. P., Ng, A. Y., & Rajpurkar, P. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00936-9 · Cited by 442 · cited 1× · see citing works
“For instance, linking images from chest X-rays to corresponding report text data, and foundation models can alleviate the need for time-consuming and laborious manual annotation while preserving human-level accuracies and outperforming supervised methods 18 .”
BackgroundTowards Expert-Level Medical Question Answering with Large Language Models
Singhal, K., Tu, T., Gottweis, J., Sayres, R., Wulczyn, E., Hou, L., Clark, K., Pfohl, S., Cole-Lewis, H., Neal, D., et al. (2023) · arXiv · doi:10.48550/arxiv.2305.09617 · Cited by 338 · cited 2× · see citing works
“Solving USMLE questions is a common benchmark test for LLMs, yet it is of limited use for real-world applications.”
BackgroundInfluentialA generalist vision-language foundation model for diverse biomedical tasks
Zhang, K., Zhou, R., Adhikarla, E., Yan, Z., Liu, Y., Yu, J., Liu, Z., Chen, X., Davison, B. D., Ren, H., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03185-2 · Cited by 333 · see citing works
Large language model AI chatbots require approval as medical devices
Gilbert, S., Harvey, H., Melvin, T., Vollebregt, E., & Wicks, P. (2023) · Nature Medicine · doi:10.1038/s41591-023-02412-6 · Cited by 207 · cited 1× · see citing works
“Thirdly, the integration of such models in operable clinical software systems faces legal and regulatory challenges because these models require approval as medical devices 26 .”
BackgroundBreaking into the black box of artificial intelligence
Savage, N. (2022) · Nature · doi:10.1038/d41586-022-00858-1 · Cited by 124 · see citing works
M. D. Anderson Breaks With IBM Watson, Raising Questions About Artificial Intelligence in Oncology
Schmidt, C. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx113 · Cited by 75 · see citing works
Virchow: A Million-Slide Digital Pathology Foundation ModelPreprint
Vorontsov, E., Bozkurt, A., Casson, A., Shaikovski, G., Zelechowski, M., Liu, S., Severson, K., Zimmermann, E., Hall, J., Tenenholtz, N., et al. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2309.07778 · Cited by 64 · cited 1× · see citing works
“…and case-speci fi c information yielding high performance in disease https://doi.org/10.1038/s41698-024-00573-2 detection as well as biomarker prediction and can also inform further diagnostic procedures such as additional stains 20,21 .”
BackgroundInfluentialXrayGPT: Chest Radiographs Summarization using Medical Vision-Language ModelsPreprint
Thawakar, O., Shaker, A., Mullappilly, S. S., Cholakkal, H., Anwer, R. M., Khan, S., Laaksonen, J. T., & Khan, F. S. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2306.07971 · Cited by 40 · cited 1× · see citing works
“In clinical practice, such models may be deployedin the form of chatbot assistants that can aid diagnosis in an interactive manner 19 .”
BackgroundA Foundational Multimodal Vision Language AI Assistant for Human PathologyPreprint
Lu, M. Y., Chen, B., Williamson, D. F. K., Chen, R. J., Ikamura, K., Gerber, G. K., Liang, I., Le, L. P., Ding, T., Parwani, A. V., et al. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2312.07814 · Cited by 18 · cited 1× · see citing works
“…and case-speci fi c information yielding high performance in disease https://doi.org/10.1038/s41698-024-00573-2 detection as well as biomarker prediction and can also inform further diagnostic procedures such as additional stains 20,21 .”
BackgroundInfluential
Flagged first, then by citations
Research works printed but not linked: 3
- Vaswani, A. et al. Attention is all you need. Preprint at https://arxiv.org/abs/1706.03762 (2017). · arXiv
- Wei, J. et al. Emergent abilities of large language models. Preprint at https://arxiv.org/abs/2206.07682 (2022). · arXiv
- Zhang, K. et al. BiomedGPT: a unified and generalist biomedical generative pre-trained transformer for vision, language, and multimodal tasks. Preprint at https://arxiv.org/abs/2305.17100 (2023). · arXiv
Cited by
Sorted by citations
Freyer, O., Wiest, I. C., Kather, J. N., & Gilbert, S. (2024) · The Lancet Digital Health · doi:10.1016/s2589-7500(24)00124-9 · Cited by 162 · see citing works
Self-citationLarge language models and their applications in bioinformatics
Sarumi, O. A., & Heider, D. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.09.031 · Cited by 91 · see citing works
Large language model use in clinical oncology
Carl, N., Schramm, F., Haggenmüller, S., Kather, J. N., Hetz, M. J., Wies, C., Michel, M. S., Wessels, F., & Brinker, T. J. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00733-4 · Cited by 85 · see citing works
Self-citationLarge Language Model Applications for Health Information Extraction in Oncology: Scoping Review
Chen, D., Alnassar, S. A., Avison, K. E., Huang, R. S., & Raman, S. (2025) · JMIR Cancer · doi:10.2196/65984 · Cited by 66 · see citing works
“Another minor disadvantage is the token limit of many LLMs, including both BERT and ChatGPT [20,42,44].”
Current status and future directions of explainable artificial intelligence in medical imaging
Saw, S. N., Yan, Y. Y., & Ng, K. H. (2024) · European Journal of Radiology · doi:10.1016/j.ejrad.2024.111884 · Cited by 54 · see citing works
Generative Artificial Intelligence in Anatomic Pathology
Brodsky, V., Ullah, E., Bychkov, A., Song, A. H., Walk, E. E., Louis, P., Rasool, G., Singh, R. S., Mahmood, F., Bui, M. M., et al. (2025) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2024-0215-ra · Cited by 48 · see citing works
Chakraborty, C., Bhattacharya, M., Pal, S., Chatterjee, S., Das, A., & Lee, S. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.02.011 · Cited by 48 · see citing works
“It represents a significant shift from the specialized, niche models of the 2010s [118].”
Collaborative, T. C. (2025) · BMJ · doi:10.1136/bmj-2024-083305 · Cited by 50 · see citing works
“67 Indeed, beyond the level of study funding, some investigators might be subject to financial bias on an individual level because they work with industry.”
Ardic, N., & Dinc, R. (2025) · Health Informatics Journal · doi:10.1177/14604582251366141 · Cited by 32 · see citing works
“23 CDSSs are essential tools in modern healthcare, helping physicians, nurses, and pharmacists make better-informed decisions about patient care.”
The barriers to uptake of artificial intelligence in hepatology and how to overcome them
Clusmann, J., Balaguer‐Montero, M., Bassegoda, O., Schneider, C. V., Seraphin, T. P., Paintsil, E. K., Luedde, T., Pérez-López, R., Caldéraro, J., Gilbert, S., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.07.003 · Cited by 29 · see citing works
Self-citationRetractedApplications of Multimodal Artificial Intelligence in Non-Hodgkin Lymphoma B Cells
Isavand, P., Aghamiri, S. S., & Amin, R. (2024) · Biomedicines · doi:10.3390/biomedicines12081753 · Cited by 24 · see citing works
“Artificial intelligence (AI) has become essential in integrating large data scales to picture tumor behavior and treatment response [1–3].”
BackgroundIntegrating large language models in care, research, and education in multiple sclerosis management
Inojosa, H., Voigt, I., Wenk, J., Ferber, D., Wiest, I. C., Antweiler, D., Weicken, E., Gilbert, S., Kather, J. N., Akgün, K., et al. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241277376 · Cited by 25 · see citing works
Self-citationHow AI agents will change cancer research and oncology
Lee, Y., Ferber, D., Rood, J., Regev, A., & Kather, J. N. (2024) · Nature Cancer · doi:10.1038/s43018-024-00861-7 · Cited by 23 · see citing works
Self-citationShikino, K., Shimizu, T., Otsuka, Y., Tago, M., Takahashi, H., Watari, T., Sasaki, Y., Iizuka, G., Tamura, H., Nakashima, K., et al. (2024) · JMIR Medical Education · doi:10.2196/58758 · Cited by 21 · see citing works
“Studies published in 2024 [30-32] provide evidence of the rapidly increasing capabilities of large language models (LLMs) like GPT-4 in various medical domains, including oncology, where AI is expected to significantly impact precision medicine [30].”
BackgroundCancer workforce—a global crisis: a Lancet Oncology Commission
Hricak, H., Ward, Z. J., Moraes, F. Y., Scott, A. M., Dako, F., Ngwa, W. F., Villarreal-Garza, C. M., Abdel-Wahab, M., Avery, S. M., Addai, B. W., et al. (2026) · The Lancet Oncology · doi:10.1016/s1470-2045(26)00065-3 · Cited by 22 · see citing works
Incidental Prompt Injections on Vision–Language Models in Real-Life Histopathology
Clusmann, J., Schulz, S., Ferber, D., Wiest, I. C., Fernandez, A., Eckstein, M., Lange, F., Reitsam, N. G., Kellers, F., Schmitt, M. P., et al. (2025) · NEJM AI · doi:10.1056/aics2500078 · Cited by 16 · see citing works
Self-citationAssessing Large Language Models for Oncology Data Inference From Radiology Reports
Chen, L.-C., Zack, T. I., Demirci, A., Sushil, M., Miao, B. Y., Kasap, C., Butte, A. J., Collisson, E. A., & Hong, J. C. (2024) · JCO Clinical Cancer Informatics · doi:10.1200/cci.24.00126 · Cited by 15 · see citing works
“30,31”
Freyer, O., Wiest, I. C., & Gilbert, S. (2025) · Mayo Clinic Proceedings Digital Health · doi:10.1016/j.mcpdig.2025.100196 · Cited by 12 · see citing works
Ten challenges and opportunities in computational immuno-oncology
Bao, R., Hutson, A. D., Madabhushi, A., Jönsson, V. D., Rosario, S. R., Barnholtz‐Sloan, J. S., Fertig, E. J., Marathe, H. G., Harris, L. N., Altreuter, J., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009721 · Cited by 13 · see citing works
“91 Using histopathology images and annotations sourced from social media and public databases, researchers have pioneered generative AI capable of identifying and annotating tumor, immune, and other cell types to assist with pathology education and diagnosis.”
Hamamoto, R., Koyama, T., Takahashi, S., Yasuda, T., Kobayashi, K., Akagi, Y., Kouno, N., Sudo, K., Hirata, M., Sunami, K., et al. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01781-y · Cited by 8 · see citing works
“…of generative AI in advancing precision oncology, the clinical implementation of multi-modal foundation models (VLM/pathology FMs) capable of understanding and generating insights across radiological images (X-ray, CT, MRI) and whole-slide pathology images (WSIs) is crucial [34, 135, 146–152].”
Rahman, M. A., & Al-Hazzaa, S. A. F. (2024) · Globecom · doi:10.1109/globecom52923.2024.10901624 · Cited by 9 · see citing works
Borat, S., & Chowdhury, S. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100265 · Cited by 9 · see citing works
Du, R. F., Carbonell, E. L., Huang, J., Liu, S., Wang, X., Shen, D. G., & Ke, J. (2025) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2025.3551913 · Cited by 9 · see citing works
Chang, L., Li, H., Wu, W., Liu, X., Yan, J., Chen, Z., Wu, H., & Song, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07591-z · Cited by 9 · see citing works
Hendriks, H. R. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189467 · Cited by 9 · see citing works
Ferreira, J., Darabi, R., Sousa, A. J., Brueckner, F. P., Reis, L. P., Reis, A. R., Tavares, J. M. R. S., & Sousa, J. (2025) · Journal of Intelligent Manufacturing · doi:10.1007/s10845-025-02614-4 · Cited by 6 · see citing works
“Multimodal Learning has been widely applied in several fields, including robotics and control (Shervedani et al., 2024), healthcare (Truhn et al., 2024), music generation (Kang et al., 2024), autonomous driving (Teshima et al., 2024; Yue et al., 2024), and environmental protection (Shadrin et al.,…”
Limited impact of real-world evidence in medical oncology: How can AI turn the tide
Pellat, A., & Kather, J. N. (2025) · European Journal of Cancer · doi:10.1016/j.ejca.2025.115714 · Cited by 6 · see citing works
Self-citationFu, J., Huang, X., Fang, M., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012468 · Cited by 5 · see citing works
Pinard, C. J., Poon, A. C., Lagree, A., Wu, K., Li, J., & Tran, W. T. (2024) · Veterinary and Comparative Oncology · doi:10.1111/vco.13035 · Cited by 6 · see citing works
Natural language generation in healthcare: A review of methods and applications
Lyu, M., Li, X., Chen, Z., Pan, J., Peng, C., Talankar, S., & Wu, Y. (2026) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2026.104997 · Cited by 10 · see citing works
Mavrych, V., Yousef, E. M., Yaqinuddin, A., Shaikh, A. A., & Bolgova, O. (2026) · PLOS Digital Health · doi:10.1371/journal.pdig.0001306 · Cited by 5 · see citing works
How AI will transform cancer care
Kather, J. N., & Abernethy, A. P. (2024) · Annals of Oncology · doi:10.1016/j.annonc.2024.08.2335 · Cited by 4 · see citing works
Self-citationSirisha, U., Kumar, C. K., Durgam, R., Eswaraiah, P., & Nagamani, G. M. (2025) · Computers, materials & continua/Computers, materials & continua (Print) · doi:10.32604/cmc.2025.063721 · Cited by 6 · see citing works
Granata, V., Fusco, R., Pupo, D., Alfieri, A., Caranci, F., Riga, M. G., Feo, M. E. D., Sgariglia, L., Carrafiello, G., Karaboue, M. A., et al. (2025) · Infectious Agents and Cancer · doi:10.1186/s13027-025-00695-7 · Cited by 3 · see citing works
“Precision treatment, tailored to the individual patient rather than directed at a specific type of neoplasm, is becoming increasingly common in oncological settings [1, 2].”
Bharath, M., Raman, R. K. S., & Alankar, A. (2025) · Progress in Materials Science · doi:10.1016/j.pmatsci.2025.101636 · Cited by 3 · see citing works
Li, K., Wang, C., Xiong, Y., Song, Y., Zhang, Y., 牟丹蕾, Hu, C., Guo, D., Mei, T., Li, A., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1710529 · Cited by 2 · see citing works
“They are also evolving into multimodal models capable of processing images and texts (34, 35), which help in identifying complex patterns in medical images that traditional methods might miss (33, 36).”
Yang, F., Yu, B., Zhou, Y., Luo, X., Tu, Z., & Liu, C. (2026) · Engineering Applications of Artificial Intelligence · doi:10.1016/j.engappai.2026.115186 · Cited by 2 · see citing works
Qi, X. S., Wang, Y., Yang, X., Ren, L., Liu, W., Benedict, S., Xiao, Y., Xing, L., & Naqa, I. M. E. (2026) · Medical Physics · doi:10.1002/mp.70616 · Cited by 2 · see citing works
“However, the emergence of data-driven techniques, particularly AI and generative AI has changed the landscape of outcome modeling in oncology including radiation therapy, 103,106–108 as will be discussed next.”
Deng, J., Wei, K., Fang, J., & Li, Y. (2024) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2024.104684 · Cited by 2 · see citing works
Assessing Large Language Models for Oncology Data Inference from Radiology ReportsPreprint
Chen, L.-C., Zack, T. I., Demirci, A., et al. (2024) · medRxiv · doi:10.1101/2024.05.23.24307579 · Cited by 2 · see citing works
Qing, L., Xue, W. X., Meng, L., Zhu, Y., & Li, J. (2025) · Frontiers in Education · doi:10.3389/feduc.2025.1640684 · Cited by 1 · see citing works
Exploring Artificial Intelligence's Potential to Enhance Conventional Anticancer Drug Development
Bobolea, S., Hinoveanu, M. I., Dimitriu, A., Brașoveanu, M., Iliescu, C., Dinu‐Pîrvu, C., Ghica, M. V., Anuța, V., Popa, L., & Prisada, R. M. (2025) · Drug Development Research · doi:10.1002/ddr.70182 · Cited by 2 · see citing works
Hierarchical agent reflection for aligning LLM reasoning with clinical diagnostic processes
Wang, X., Li, X., Zhao, D., Feng, K., Liang, L., Zhang, Z., Ding, K., Chen, H., Wan, B., & Zhang, Q. (2026) · Health Information Science and Systems · doi:10.1007/s13755-025-00410-1 · Cited by 1 · see citing works
Xu, K., Xu, Y., & Shi, Q. (2026) · Intelligent Oncology · doi:10.1016/j.intonc.2026.100038 · Cited by 1 · see citing works
A Contrastive Variational AutoEncoder for NSCLC Survival Prediction with Missing Modalities
Zanitti, M., Miskovic, V., Trovò, F., Pedrocchi, A., Shen, M., Tun, Y. K., Prelaj, A., & Kosta, S. (2025) · IEEE International Conference on Big Data (BigData) · doi:10.1109/bigdata66926.2025.11401431 · Cited by 1 · see citing works
“This progress is largely driven by an increased research interest in multimodal learning, which aims to simultaneously integrate diverse data inputs, representing a transition from conventional unimodal models that analyze single data types in isolation [1].”
Ding, Y., Wei, S., Holmes, J., Hao, Y., Liu, Z., Wang, P., Cui, J., Cao, M., Jiang, C., Zhao, L., et al. (2026) · Meta-Radiology · doi:10.1016/j.metrad.2026.100244 · Cited by 1 · see citing works
Precision oncology: from large language models to multi-agent systems
Guo, X., Chen, J., Zhang, Y., Zhang, X., Lu, J., Qin, Q., Chen, J., Gao, X., & Wang, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1828507 · Cited by 3 · see citing works
“…evolution of generative AI in medicine, the general architectural paradigms of medical AI agents and multi-agent systems, the potential implications of AI agents for oncology, and the emerging roles of large language models and multimodal foundation models in precision oncology (2, 4, 5, 9, 11).”
Wang, H., Xie, X., Liu, E., Gao, Y., Wu, X., Cong, S., Han, J., Zhang, N., Zheng, H., Liang, D., et al. (2026) · Research · doi:10.34133/research.1343 · Cited by 1 · see citing works
“Still, this line of work is inherently post hoc: it does not address the unmet need in precision oncology for a staging-aware PET/CT drafting framework whose TNM conclusions are grounded in image-derived evidence rather than inferred from an already-written report [ 20 – 22 ].”
Machine Learning for Radiomics in Oncology: Challenges, Limitations, and Future Directions
Missaoui, R., Saadaoui, W., Coco, M. D., Helali, A., Leo, M., & Carcagnì, P. (2026) · Sensors · doi:10.3390/s26144619 · Cited by 2 · see citing works
Perspective on Harnessing Large Language Models to Uncover Insights in Diabetes Wearable DataPreprint
Alavi, A., Cha, K., Esfarjani, D. P., Patel, B. J., Li‐Pook‐Than, J., Lee, A., Nebeker, C., Snyder, M. P., & Bahmani, A. H. (2024) · medRxiv · doi:10.1101/2024.07.29.24310315 · Cited by 1 · see citing works
“For example, LLMs have been employed to identify appropriate treatments for cancer patients, support decision-making in tumor boards, and predict disease progression in neurodegenerative disorders 21,22 .”
MethodClusmann, J., Schulz, S., Ferber, D., Wiest, I. C., Fernandez, A., Eckstein, M., Lange, F., Reitsam, N. G., Kellers, F., Schmitt, M. P., et al. (2024) · medRxiv · doi:10.1101/2024.12.11.24318840 · Cited by 1 · see citing works
Self-citationChen, J. H., Elmelech, L., Tang, A. L., & Hacohen, N. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2024.102463
Einsatz der künstlichen Intelligenz in der Diagnostik und Therapie solider Tumoren
Peeken, J. C., & Kather, J. N. (2025) · Die Onkologie · doi:10.1007/s00761-025-01683-7
Self-citationKather, J. N. (2025) · Springer eBooks · doi:10.1007/978-3-662-71042-5_5
Self-citationZukunftsperspektiven von Künstlicher Intelligenz in der Medizin
Kather, J. N. (2025) · Springer eBooks · doi:10.1007/978-3-658-47498-0_4
Self-citationPathology’s Last Exam: Stress-Testing Diagnostic Reasoning and Safety in Large Language ModelsPreprint
Reitsam, N. G., Gustav, M., Jesinghaus, M., et al. (2025) · medRxiv · doi:10.64898/2025.12.11.25342081
Self-citationMastroleo, F., Borras-Osorio, M., Patel, S. P., Peterson, S. M., Wilson, R., Namazi, M. J., Zhou, M., Shiraishi, S., Foong, A., Routman, D. M., et al. (2025) · Technical Innovations & Patient Support in Radiation Oncology · doi:10.1016/j.tipsro.2025.100372 · Cited by 1 · see citing works
“Collectively, these developments in different fields [25,26] show the trends seen in radiation oncology, where models with language understanding, whether generalist LLMs or domain-specific transformers, are increasingly enabling the extraction of clinically relevant information from unstructured…”
Hao, K., & Wang, B. (2026) · Digital Medicine · doi:10.1097/dm-2025-00015 · Cited by 1 · see citing works
Salome, P., Knoll, M., Walz, D., Cogno, N., Dedeoglu, A. S., Qi, A. L., Isakoff, S. J., Abdollahi, A., Jimenez, R. B., Bitterman, D. S., et al. (2026) · npj Digital Medicine · doi:10.1038/s41746-026-03170-8
Wang, Z., Ma, T., & Wang, H. (2026) · Die Radiologie · doi:10.1007/s00117-026-01608-4 · Cited by 2 · see citing works
Yin, Y., Ke, S., Liu, Y., Wang, X., Xue, Q., & Sun, W. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/4207980
Shi, Q., Lou, N., & Xue, C. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1769097 · Cited by 1 · see citing works
Sousa, J., Darabi, R., Sousa, A. J., Brueckner, F. P., Reis, L. P., & Reis, A. (2026) · Computer Vision and Image Understanding · doi:10.1016/j.cviu.2026.104771
SCRIPT: Stratified clinical risk prediction from pathology reports using large language models
Loeffler, C. M. L., Reitsam, N. G., Wolf, F., Stueker, E. H., Muti, H. S., Wiest, I. C., & Kather, J. N. (2026) · Journal of Pathology Informatics · doi:10.1016/j.jpi.2026.100673
“18,19 Because pathology reports summarize microscopic fi ndings that are themselves strongly prognostic, LLM-derived scores may serve as an ef fi cient extra representation for downstream multimodal models, particularly in institutions, where digital pathology imaging is not yet widely available.”
Self-citationLiyue, G., Wen, T., Zeng, X., Liu, X., Li, M., Sun, J., & Zheng, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1592750
Raj, D. T., Dhanush, N., N., C. S., Poornima, P., & Raju, S. P. (2026) · AIP conference proceedings · doi:10.1063/5.0327228
Vorwerk, J., Leypoldt, L. B., Schwandt, J., Kohler, J., Nimmagadda, S. C., Ahmed, H., Patnana, P. K., Hönemann, H., Helbing, T., Feierabend, S., et al. (2026) · Oncology Research and Treatment · doi:10.1159/000553462
Menz, B. D., Scarfo, N. L., Cornelisse, E., Shahnam, A., Chin-Yee, B. H., Rickard, C., Haseloff, M., Lau, A. Y. S., Ugalde, A., Paterson, C. C., et al. (2026) · European Journal of Cancer · doi:10.1016/j.ejca.2026.116990 · Cited by 1 · see citing works
From data to value in multimodal learning
Tang, C., Xing, J., & Xiong, Y. (2026) · Patterns · doi:10.1016/j.patter.2026.101615
Zhao, W., Chen, L., Pu, W., Liu, L., Tan, X., Li, S., Qiu, X., Fan, J., Zhu, M., & Wang, Z. (2026) · Expert Systems with Applications · doi:10.1016/j.eswa.2026.134108
Digital pathology, image analysis, and artificial intelligence in liver disease
McGenity, C., Treanor, D. E., Slavík, T., & Goldin, R. D. (2026) · The Lancet Digital Health · doi:10.1016/j.landig.2026.101017
Generative artificial intelligence technologies in pathology
Ullah, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40383-5.00013-3
Multimodal Artificial Intelligence in Lung Cancer: From Data Integration to Precision Oncology
Chakrabarti, T., Mansour, A. G., Wu, X., Arias-Romero, J., Mambetsariev, I., Chang, N., Santos, S. D., Mirzapoiazova, T., Fricke, J., Kim, J., et al. (2026) · Cancers · doi:10.3390/cancers18182953
“Foundation models that have been pre-trained on large-scale medical data can be used to perform transfer learning with disease-specific multimodal data cohorts that have relatively smaller sample sizes [121].”
Investigación científica en la era de la inteligencia artificial
Pluas, R. E. M., Fernández-Loor, A. O., Mendizábal, V. L. L., Sánchez-Vivanco, J. P., Urbano, A. P. M., & Angulo, R. M. M. (2026) · doi:10.70577/pd8w9r97
Optimizing the delivery of radiotherapy with artificial intelligence
Katsoulakis, E., & Naqa, I. E. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01204-4
Wang, Z.-Y., Liu, N., & Chen, M. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1875788
Lee, K. (2026) · Journal of Robotic Surgery · doi:10.1007/s11701-026-03966-6
Stylianakis, D., Sánchez-Bayona, R., Denaro, N., & Solinas, C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1953714
- Authors
- Truhn, D., Eckardt, J.-N., Ferber, D., & Kather, J. N.
- Affiliations
- Universitätsklinikum Aachen (DE)
- University Hospital Carl Gustav Carus (DE)
- Heidelberg University (DE)
- Corresponding author
- Kather, Jakob Nikolas
- Venue
- npj Precision Oncology
- Published
- 2024-03-22
- Volume
- 8
- Issue
- 1
- Pages
- 72-72
- ISSN
- 2397-768X (ISSN-L)
- PMC
- PMC10959931
- OpenAlex
- W4393078503
- Semantic Scholar
- 7e9cd89173fa68a5bd8cc5cb7aa68df172f603a2
- Cited by
- 79
- References
- 30
- Citations by year
- 2026: 37 · 2025: 25 · 2024: 17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- npj Precision Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PUBLISSO (German National Library of Medicine) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion, other-oa)
- RWTH Publications (RWTH Aachen)
- Funders
- Amgen
- AstraZeneca
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Multimodal Machine Learning Applications
- Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
- Keywords
- large language models, multimodal foundation models, precision oncology, cancer research, transformer models, multimodal AI, artificial intelligence in oncology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review